Contents

Rna SequencingEdit

RNA sequencing is a collection of laboratory techniques and computational analyses that decode the transcriptome—the full set of RNA transcripts produced by an organism or a cell under specific conditions. By converting RNA into complementary DNA (cDNA) and then sequencing it, researchers can measure how much of each transcript is present, discover novel transcripts and splice variants, identify RNA editing events, and explore the regulatory layers that govern gene expression. This technology has become foundational for modern molecular biology, enabling insights from basic biology to clinical diagnostics.

RNA sequencing emerged from the broader revolution of high-throughput sequencing and has evolved through several generations of platforms and methods. Early approaches relied on sequencing short fragments of RNA-derived cDNA, but rapid advances in chemistry, chemistry-enabled detection, and computational power transformed RNA sequencing into a scalable, genome-wide assay. Today, researchers can choose between short-read technologies that deliver large sample throughput and long-read technologies that capture full-length transcripts, each with distinct advantages for different research questions. Next-generation sequencing and Illumina are central to many workflows, while companies such as PacBio and Oxford Nanopore Technologies provide long-read capabilities that illuminate transcript structure in ways that short reads sometimes miss. The development of RNA sequencing has gone hand in hand with improvements in library preparation, sequencing chemistry, and bioinformatics, creating an integrated ecosystem for data generation and interpretation. See also Transcriptomics and Gene expression.

Methods

Library preparation

The typical RNA-seq workflow begins with extracting RNA from the sample, followed by selection or depletion steps to enrich for the RNA species of interest. For many experiments, researchers enrich for messenger RNA (mRNA) by targeting polyadenylated tails, yielding a pool enriched for protein-coding transcripts. Others remove ribosomal RNA (rRNA) or selectively capture noncoding RNAs to broaden the view of the transcriptome. The RNA is then fragmented and reverse-transcribed into cDNA, adapters are added, and the library is amplified to create a sequencing-ready material. Library preparation choices influence which RNA species are captured and how accurately transcript abundance and structure can be quantified. See RNA and mRNA.

Sequencing platforms

Short-read sequencing (for example, on platforms from Illumina) generates vast amounts of data in relatively small fragments, which supports precise quantification of expression levels for annotated genes and discovery of novel transcripts through computational assembly. Long-read sequencing (on platforms from PacBio and Oxford Nanopore Technologies) can read full-length transcripts, enabling direct observation of isoforms and complex splice patterns without assembly, but often at higher per-base cost or with higher error rates that are mitigated by newer chemistries and polishing algorithms. Researchers commonly combine approaches to leverage the strengths of each. See also Single-molecule sequencing and Long-read sequencing.

Data processing and analysis

Raw sequencing reads are aligned to a reference genome or transcriptome, or assembled de novo in organisms without a well-annotated genome. Quantification steps translate read counts into measures of transcript abundance, such as transcripts per million (TPM) or fragments per kilobase of transcript per million mapped reads (FPKM). Downstream analyses identify differentially expressed genes, alternative splicing events, and fusion transcripts, among other features. Data interpretation depends on careful experimental design, appropriate normalization, and awareness of technical biases introduced during sample preparation and sequencing. See Bioinformatics and Differential expression analysis.

Applications and impact

Basic research

RNA sequencing provides a global view of how cells respond to stimuli, developmental cues, or environmental stress. It enables the mapping of expression networks, discovery of novel transcripts, and exploration of noncoding RNA functions. In model organisms, researchers can compare transcriptomes across tissues, developmental stages, or mutants to infer regulatory relationships. See Gene regulation and Noncoding RNA.

Clinical and translational uses

In medicine, RNA sequencing informs cancer profiling, infectious disease research, and rare disease investigations by revealing gene expression signatures, splice variants, and potential therapeutic targets. It also underpins efforts in personalized medicine, where transcriptomic information complements genomic data to guide treatment decisions and prognosis. See Precision medicine and Clinical genomics.

Emerging directions

Single-cell RNA sequencing (scRNA-seq) dissects gene expression at the level of individual cells, uncovering cellular heterogeneity that bulk RNA-seq can overlook. Spatial transcriptomics integrates gene expression data with tissue architecture, adding a spatial dimension to transcriptome analysis. Together, these frontiers enable more nuanced models of biology and disease. See Single-cell RNA sequencing and Spatial transcriptomics.

Limitations and considerations

  • Technical biases can arise from sample handling, library preparation, and sequencing chemistry, which may affect sensitivity for low-abundance transcripts or certain GC content ranges. Careful experimental design and appropriate controls are essential. See Bias (statistics) and Normalization.
  • Quantification accuracy depends on alignment strategies and annotation quality; poorly annotated genomes may limit discovery or misclassify transcripts. See Transcript annotation.
  • Interpretation of differential expression or isoform usage requires context about tissue, condition, and cell type; results are most informative when integrated with other data types (e.g., proteomics, epigenomics). See Multi-omics.
  • Data privacy and consent are important when human samples are involved, and ethical frameworks guide access, sharing, and secondary use of transcriptomic data. See Ethics in genomics.

See also